Celal Özbek Çakır | chemotherapy | Innovative Research Award

Innovative Research Award

Celal Özbek Çakır
Karamanoğlu Mehmet Bey University, Turkey

Celal Özbek Çakır
Affiliation Karamanoğlu Mehmet Bey University
Country Turkey
Subject Area Chemotherapy
Event International Research Awards on Oncology and Cancer Research
ORCID 0000-0002-3618-6033

Celal Özbek Çakır is a researcher affiliated with Karamanoğlu Mehmet Bey University in Turkey whose stated subject area is chemotherapy. This recognition profile presents the researcher in the context of the Innovative Research Award associated with the International Research Awards on Oncology and Cancer Research. The profile is based on the identifying and affiliation information supplied for the award record, together with persistent researcher-identification information available through ORCID. [1]

Abstract

This academic recognition profile concerns Celal Özbek Çakır of Karamanoğlu Mehmet Bey University, Turkey, with chemotherapy identified as the principal subject area. The profile is associated with the Innovative Research Award within the International Research Awards on Oncology and Cancer Research. The researcher is identified through the ORCID persistent identifier 0000-0002-3618-6033, which provides a standardized mechanism for distinguishing researchers and connecting their scholarly activities with an individual record. [2]

Keywords

Keywords: chemotherapy, oncology research, cancer research, cancer treatment, anticancer therapy, therapeutic research, drug response, oncology pharmacology, innovative research, translational oncology, Karamanoğlu Mehmet Bey University, Turkey, Innovative Research Award.

Introduction

Chemotherapy is an established component of cancer treatment research and encompasses the investigation and clinical application of medicines that can interfere with the growth, division, or survival of cancer cells. Contemporary oncology research also examines how therapeutic approaches can be optimized through combination strategies, treatment sequencing, biomarker-informed approaches, and improved management of treatment-related effects. The National Cancer Institute describes chemotherapy as a cancer treatment that uses drugs to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. [3]

Research Profile

Celal Özbek Çakır is affiliated with Karamanoğlu Mehmet Bey University in Turkey. The supplied academic profile identifies chemotherapy as the relevant subject area and associates the researcher with the Innovative Research Award. The researcher’s ORCID iD is 0000-0002-3618-6033. ORCID identifiers are persistent identifiers designed to distinguish researchers and support reliable attribution of scholarly work across systems. [2]

Research Contributions

The stated research area of chemotherapy places the profile within cancer-treatment research. Potential contribution areas in this domain include the study of anticancer agents, mechanisms of drug action, treatment resistance, combination therapies, therapeutic optimization, and strategies for improving the safety or effectiveness of cancer treatment. However, individual contribution claims require supporting publication or institutional evidence and should not be attributed to the researcher without verification.

Publications

A verified publication list was not supplied as part of the profile data. Consequently, specific articles, journal titles, publication dates, citation counts, and DOI records are not attributed to Celal Özbek Çakır in this section. A complete publication assessment should be conducted using the researcher’s ORCID record and authoritative bibliographic databases, with author identity and affiliation checked for each publication. [1] [2]

Research Impact

Research impact in oncology may be reflected through several forms of scholarly and practical contribution, including peer-reviewed publications, citation and reuse of research findings, methodological advances, collaborative research, translational applications, and contributions to evidence used in cancer treatment. Citation counts and h-index values can be useful descriptive indicators, but they should be interpreted in relation to discipline, career stage, database coverage, and publication history.

Award Suitability

The Innovative Research Award is presented in the context of the International Research Awards on Oncology and Cancer Research. Based on the supplied profile information, the researcher’s stated subject area of chemotherapy is directly situated within cancer-treatment research. This establishes topical relevance to an oncology-focused research recognition program.

Conclusion

Celal Özbek Çakır is identified in the supplied award profile as a researcher affiliated with Karamanoğlu Mehmet Bey University, Turkey, with chemotherapy as the stated subject area and ORCID iD 0000-0002-3618-6033. The profile connects the researcher with the Innovative Research Award under the International Research Awards on Oncology and Cancer Research. [2]

References

  1. 1.Elsevier. (n.d.): Abstract and citation database and author profiles. Scopus.
    https://www.scopus.com/
  2. 2.ORCID. (n.d.). ORCID: Connecting research and researchers. ORCID.
    https://orcid.org/0000-0002-3618-6033
  3. 3.National Cancer Institute.(n.d.).Chemotherapy to Treat Cancer. National Cancer Institute.
    https://www.cancer.gov/about-cancer/treatment/types/chemotherapy
  4. 4.International DOI Foundation. (n.d.). DOI Handbook. International DOI Foundation.
    https://www.doi.org/the-identifier/resources/factsheets/doi-handbook
      5. International Research Awards on Oncology and Cancer Research
       https://doi.org/10.1179/016164107X159225

Prof. Sobhi Gomha | Chemotherapy | Best Researcher Award

Prof. Sobhi Gomha | Chemotherapy | Best Researcher Award

Islamic University of Madinah | Saudi Arabia

Author Profile

Scopus

Google Scholar

Orcid id

Personal Data:

  • Name: Sobhi Mohamed Gomha
  • Date of Birth: 1972
  • Place of Birth: Fayoum, Egypt
  • Nationality: Egyptian
  • Gender and Marital Status: Male, Married
  • Occupation: Professor of Organic Chemistry
  • Institutions:
    • Faculty of Science, Cairo University, Giza, Egypt.
    • Faculty of Science, Islamic University of Madinah, Madinah, Saudi Arabia.
  • Addresses:
    • Permanent: Faculty of Science, Cairo University, Giza 12613, Egypt; Chemistry Department
    • Resident: Faculty of Science, Islamic University of Madinah, Madinah 42351, Saudi Arabia.
  • Contact:

Certificates and Qualifications:

  • B.Sc. (Chemistry): 1995, Cairo University – Faculty of Science.
  • Pre-master courses: 1996-1997
  • M.Sc. (Organic Chemistry): 2002, Cairo University – Faculty of Science.
  • Ph.D. (Organic Chemistry): 2006, Cairo University – Faculty of Science.
  • Associate Professor: January 2012, Cairo University – Faculty of Science.
  • Full Professor: January 2017, Cairo University – Faculty of Science.

Research Interests:

  • Green Synthesis: Focus on the green synthesis of novel heterocyclic compounds using eco-friendly technologies like Microwave Irradiation, Ultrasonic radiation, Grinding, and Ionic Liquids.
  • Applications: Biological and industrial applications with an emphasis on reducing hazardous substances and energy usage.

Online Profiles:

Publications and Metrics:

  • Total Publications: 270 (257 published papers: 240 research papers, 17 review articles) + 13 books.
  • Citations:
    • Google Scholar: 6730
    • Scopus: 5600
    • Web of Science: 6280
    • ResearchGate: 6050
  • Highly Cited Papers:
    • Google Scholar: 319
    • Scopus: 269
    • Web of Science: 250
    • ResearchGate: 269
  • H-index:
    • Google Scholar: 48
    • Scopus: 44
    • Web of Science: 44
    • ResearchGate: 43
  • i10-index: 176 (Google Scholar)

Teaching Courses:

  • General Chemistry, Aliphatic Organic Chemistry, Aromatic Organic Chemistry, Heterocyclic Chemistry, Functional Organic Chemistry, Physical Organic Chemistry, Biomolecules, Natural products, Organometallic Chemistry, Physical Pharmacy, Stereochemistry, Biochemistry, Advanced Heterocyclic Chemistry, Chemistry of Drugs, Green and Environmental Chemistry, Reactions and Mechanisms of Aliphatic Compounds, Spectroscopy (MS, IR, NMR, UV), Basic principles of Organic Chemistry for Pre-Pharmacy, Pre-Dental, Pre-Veterinary students, Practical Organic Chemistry for undergraduate students, Field Training, Graduation Project.

Professional Memberships and Achievements:

  • Scientific Societies:
    • Egyptian Society of Heterocyclic Chemistry (EHCS)
    • Performance appraisal and development committee (Cairo University)
    • Scientific culture committee (Cairo University)
    • Research Committee of the article and graduation projects (Cairo University)
    • Quality Committee, Department of Chemistry (Cairo University and Islamic University of Madinah)
    • Training and Development Committee, Faculty of Science, Islamic University of Madinah
    • Head of Chemistry Department, Faculty of Science, Islamic University of Madinah
    • Egyptian National Bioinformatics Network (BioNetMasr)
    • Scientific Research Deanship Council at the Islamic University
    • Sustainability Unit at the Islamic University
    • Supervised and launched academic programs and projects in Chemistry
    • Participated in numerous scientific and quality events

Conferences Attended:

  • Participated and presented in various international and national conferences, such as Biannual conference on chemistry (Cairo University), International conferences in Egypt, UAE, Morocco, and Saudi Arabia, Heterocyclic Chemistry meetings, Scientific Research Weeks, and Quality Weeks.

Experiences:

  • Proficient in PC software (ChemDraw, Excel, Word, PowerPoint)
  • Expertise in Mass Spectra, NMR, Organic Synthesis
  • Completed various training courses in IR, NMR, UV, GCMS, microanalytical instruments, effective presentation, new trends in teaching (E-Learning), effective teaching, credit hours education, scientific publications, utility of technology in teaching, and strategic planning.

Editorial and Reviewer Roles:

  • Editorial Board Member for 42 Journals: Including Molecules, Crystals, Scientific Reports, Mini-Reviews in Medicinal Chemistry, Current Medicinal Chemistry, and various other international journals.
  • Reviewer for 138 Journals: Including ACS Chemical Neuroscience, Acta Pharmaceutica Sinica B, Analytical Chemistry Letters, Anticancer Agents in Medicinal Chemistry, Arabian Journal of Chemistry, Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry, Journal of Medicinal Chemistry, and many more.

Reviewing PhD Theses:

  • Reviewed several PhD theses on topics like environmental cost accounting, synthesis and biological evaluation of novel compounds, green chemistry methodologies, and heterocyclic ring synthesis.

Reviewing for Promotions:

  • Reviewed scientific production for the promotion of faculty members from various universities, including Imam Abdulrahman Bin Faisal University, University of Bisha, Northern Border University, Taibah University, Taif University, and Tabuk University.

Languages:

  • English (Good), French (Fair), German (Fair)

Supervision:

  • Supervisor for 17 MSc and 9 PhD theses.

Research Projects:

  • Engaged in multiple research projects funded by various institutions, focusing on green synthesis, characterization, biological evaluation of novel compounds, separation of rare earth elements, and innovative optical organic compounds for solar cells.

Awards and Recognition:

  • Best paper in heterocyclic chemistry from the Egyptian Heterocyclic Chemistry Society (E.H.C.S) for 2015.
  • Included in the list of the World’s Top 2% Scientists by Stanford University for the years 2019, 2020, and 2021.

Notable Publication: